Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1996
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741743A1 Cyclic neurokinin a antagonists
11/13/1996EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
11/13/1996EP0741711A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741687A1 Leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741686A1 New leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741568A1 Inhibition of arthritis by l-type calcium channel antagonists
11/13/1996EP0683777B1 Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-[n-carboxamido]carboxamides as intiinflammatory agents
11/13/1996CN1135718A Method and products for controlling immune responses in mammals
11/13/1996CN1135485A 2,9-di-substituted pur-6-ones compound
11/12/1996US5574173 Inhibitors of tumor necrosis factor
11/12/1996US5574170 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration
11/12/1996US5574034 Treatment of immune diseases and excess cell proliferation, enzyme inhibitors
11/12/1996CA2105302C 1-azabicyclo¬3.2.2.|nonan-3-amine derivatives
11/07/1996WO1996034953A2 Cd16-ii variants
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034857A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0740938A2 Proline and 4-hydroxyproline as therapeutic agents
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996CN1135218A Piperidine derivatives
11/05/1996US5571843 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof
11/05/1996US5571826 Heterocyclic compounds and their preparation and use
11/05/1996US5571818 Pyrrolyl-4h-pyranoisoquinolines
11/05/1996US5571786 Analgesics and antiinflammatory agents
10/1996
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996033993A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996WO1996033730A2 Chemokine binding protein and methods of use therefor
10/31/1996WO1996033726A1 Preparation and use of sulfated oligosaccharides
10/31/1996WO1996033708A1 Irritation relief using nonsteroidal anti-inflammatory compounds
10/31/1996WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996WO1996033701A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
10/31/1996CA2219261A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996CA2219226A1 Irritation relief using nonsteroidal anti-inflammatory compounds
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/31/1996CA2216931A1 Inhibiting photodecomposition of 3-substituted-2-oxindoles
10/30/1996EP0739892A2 Chromone derivatives
10/30/1996EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
10/30/1996EP0739351A1 Monomeric diols and phosphate linked oligomers formed therefrom
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739342A1 Pyridine modulators of acetylcholine receptors
10/30/1996EP0739340A1 Phenyl heterocycles as cox-2 inhibitors
10/30/1996EP0739338A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
10/30/1996EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists
10/30/1996EP0739335A1 Pyrrolidine-containing monomers and oligomers
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134704A Drug binding protein
10/30/1996CN1134423A Adhesion receptor antagonists
10/30/1996CN1134419A N-(3-Benzofuranyl) urea-derivatives
10/30/1996CN1134417A 2,8-disubstituted quinazolinones
10/30/1996CN1134299A Tincture for dredging channel and alleviating pain and its making method
10/29/1996US5569665 Peptidyl derivatives and their use as metalloproteinases inhibitors
10/29/1996CA1338683C Fatty acid therapy and compositions
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033185A1 A process for preparing form 1 ranitidine hydrochloride
10/24/1996WO1996033176A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
10/24/1996WO1996033175A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
10/24/1996WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors
10/24/1996WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
10/24/1996WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
10/24/1996WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032946A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
10/24/1996WO1996032941A1 Pranoprofen eyedrops containing organic amine
10/24/1996WO1996032940A1 New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
10/24/1996WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists
10/24/1996CA2218562A1 A process for preparing form 1 ranitidine hydrochloride
10/24/1996CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors
10/24/1996CA2218345A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
10/24/1996CA2216882A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/23/1996EP0738715A2 Arylalkyl-pyridazinones
10/23/1996EP0738270A1 Dihydro pyrazolopyrroles
10/23/1996EP0738268A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
10/23/1996EP0738262A1 Novel heterocyclic compounds
10/23/1996EP0738151A1 Treatment using arachidonic acid metabolite and particulate formulations
10/23/1996EP0738144A1 Phenylmethyl hexanamides, and the use thereof
10/23/1996EP0738142A1 Perfluorocarbons as anti-inflammatory agents
10/23/1996CN1134153A Matrix metalloprotease inhibitors
10/23/1996CN1133839A Aroyl-piperidine derivatives
10/23/1996CN1033088C Process for preparing thiazolylbenzofuran derivs.
1 ... 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 ... 1272